Benzoyl Peroxide

Benzoyl peroxide has treated acne for decades by killing the bacteria behind breakouts, and as an active it works and is a dermatology first-line choice. What changed in 2024 is a stability problem still being resolved. Independent labs showed benzoyl peroxide can break down into benzene, a Group 1 carcinogen, faster under heat and over time. In stability testing some products formed benzene far above the limit allowed in medicines, a portion exceeded it even at room temperature, and heat like a hot car or steamy bathroom pushed levels much higher, with benzene even off-gassing from sealed packaging. The key detail: this benzene is not a manufacturing leftover to be purified out, it forms from the active drug itself. Regulators read the products as sold more reassuringly, with the FDA testing 95 products by validated methods, finding more than 90% undetectable or very low, recalling six, and calling the cancer risk from what it found very low. The human cancer evidence is thin and mixed: one large patient review found no link, a separate reporting-database signal is worth watching, and no causal link is established. So the status is unsettled, and that matters, because how much benzene sits in any tube depends on its formula, age, and storage heat, none of which you can read off the label. Since a carcinogen that forms inside the product is hard to verify and easy to accelerate with everyday heat, and since salicylic acid, adapalene, and azelaic acid treat acne without it, the cautious choice is to favor one of those. This is a precaution, not a claim these products cause cancer; the evidence does not show that, and regulators call the risk low.